Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 292 articles:
HTML format



Single Articles


    January 2021
  1. SPOGIS J, Hagen F, Thaiss WM, Hoffmann T, et al
    Sonographic findings in coronavirus disease-19 associated liver damage.
    PLoS One. 2021;16:e0244781.
    PubMed     Abstract available


  2. OHIRA S, Kanayama N, Wada K, Ikawa T, et al
    Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography.
    PLoS One. 2021;16:e0244079.
    PubMed     Abstract available


  3. ZHAO N, Tan H, Wang L, Han L, et al
    Palmitate induces fat accumulation via repressing FoxO1-mediated ATGL-dependent lipolysis in HepG2 hepatocytes.
    PLoS One. 2021;16:e0243938.
    PubMed     Abstract available


  4. SETO WK, Mandell MS
    Chronic liver disease: Global perspectives and future challenges to delivering quality health care.
    PLoS One. 2021;16:e0243607.
    PubMed    


  5. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West.
    PLoS One. 2021;16:e0244939.
    PubMed     Abstract available


  6. LI X, Zhong X, Wang Y, Zeng X, et al
    Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250602.
    PubMed     Abstract available


  7. FERSTL PG, Filmann N, Heilgenthal EM, Schnitzbauer AA, et al
    Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates.
    PLoS One. 2021;16:e0245091.
    PubMed     Abstract available


  8. DA FONSECA RD, Santos PR, Monteiro MS, Fernandes LA, et al
    Parametric evaluation of impedance curve in radiofrequency ablation: A quantitative description of the asymmetry and dynamic variation of impedance in bovine ex vivo model.
    PLoS One. 2021;16:e0245145.
    PubMed     Abstract available


  9. FRANKOVA S, Lunova M, Gottfriedova H, Senkerikova R, et al
    Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis.
    PLoS One. 2021;16:e0244934.
    PubMed     Abstract available


  10. WANG F, Numata K, Takeda A, Ogushi K, et al
    Safety and efficacy study: Short-term application of radiofrequency ablation and stereotactic body radiotherapy for Barcelona Clinical Liver Cancer stage 0-B1 hepatocellular carcinoma.
    PLoS One. 2021;16:e0245076.
    PubMed     Abstract available


  11. CARTER JK, Bhattacharya D, Borgerding JN, Fiel MI, et al
    Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales.
    PLoS One. 2021;16:e0244763.
    PubMed     Abstract available


  12. JOBIRA B, Frank DN, Silveira LJ, Pyle L, et al
    Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
    PLoS One. 2021;16:e0245219.
    PubMed     Abstract available


  13. FATTAHI N, Rezaei N, Asadi-Lari M, Yousefi M, et al
    Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis.
    PLoS One. 2021;16:e0245468.
    PubMed     Abstract available


  14. VAN AMERONGEN MJ, Vos AM, van der Woude W, Nagtegaal ID, et al
    Does perfusion computed tomography correlate to pathology in colorectal liver metastases?
    PLoS One. 2021;16:e0245764.
    PubMed     Abstract available


  15. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available


  16. CHO Y, Lee S, Park SJ
    Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    PLoS One. 2021;16:e0245911.
    PubMed     Abstract available


  17. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed     Abstract available


  18. CHEN BW, Chiu GW, He YC, Huang CY, et al
    Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid.
    PLoS One. 2021;16:e0245286.
    PubMed     Abstract available


  19. NIRIELLA MA, Ediriweera DS, Kasturiratne A, De Silva ST, et al
    Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.
    PLoS One. 2021;16:e0245762.
    PubMed     Abstract available


  20. MENDOZA N, Rivas E, Rodriguez-Roisin R, Garcia T, et al
    Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.
    PLoS One. 2021;16:e0245046.
    PubMed     Abstract available


  21. VOGL TJ, Riegelbauer LJ, Oppermann E, Kostantin M, et al
    Early dynamic changes in circulating tumor cells and prognostic relevance following interventional radiological treatments in patients with hepatocellular carcinoma.
    PLoS One. 2021;16:e0246527.
    PubMed     Abstract available


  22. SEO N, Park MS, Choi JY, Yeom JS, et al
    A prospective study on the use of ultralow-dose computed tomography with iterative reconstruction for the follow-up of patients liver and renal abscess.
    PLoS One. 2021;16:e0246532.
    PubMed     Abstract available


  23. ASSIS JB, Cogliati B, Esteves E, Capurro ML, et al
    Aedes aegypti mosquito saliva ameliorates acetaminophen-induced liver injury in mice.
    PLoS One. 2021;16:e0245788.
    PubMed     Abstract available


  24. TANAKA T, Hirooka M, Koizumi Y, Watanabe T, et al
    Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method.
    PLoS One. 2021;16:e0246315.
    PubMed     Abstract available


  25. KIM YA, Kang D, Moon H, Sinn D, et al
    Survival in untreated hepatocellular carcinoma: A national cohort study.
    PLoS One. 2021;16:e0246143.
    PubMed     Abstract available


  26. FUKUYAMA K, Asagiri M, Sugimoto M, Tsushima H, et al
    Gene expression profiles of liver cancer cell lines reveal two hepatocyte-like and fibroblast-like clusters.
    PLoS One. 2021;16:e0245939.
    PubMed     Abstract available


  27. STAHLSCHMIDT FL, Tafarel JR, Menini-Stahlschmidt CM, Baena CP, et al
    Hepatorenal index for grading liver steatosis with concomitant fibrosis.
    PLoS One. 2021;16:e0246837.
    PubMed     Abstract available


  28. TOMITA K, Chiba N, Ochiai S, Gunji T, et al
    Prognostic value of future liver remnant LU15 index of 99mTc-galactosyl serum albumin scintigraphy for predicting posthepatectomy liver failure.
    PLoS One. 2021;16:e0247675.
    PubMed     Abstract available


  29. KOVAC JD, Dakovic M, Jankovic A, Mitrovic M, et al
    The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    PLoS One. 2021;16:e0247301.
    PubMed     Abstract available


  30. KIMANYA ME, Routledge MN, Mpolya E, Ezekiel CN, et al
    Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data.
    PLoS One. 2021;16:e0247281.
    PubMed     Abstract available


  31. CHO WR, Wang CC, Tsai MY, Chou CK, et al
    Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients.
    PLoS One. 2021;16:e0247231.
    PubMed     Abstract available


  32. POMEJ K, Scheiner B, Hartl L, Balcar L, et al
    COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
    PLoS One. 2021;16:e0256544.
    PubMed     Abstract available


  33. SHIGESAWA T, Suda G, Kimura M, Maehara O, et al
    Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.
    PLoS One. 2021;16:e0247728.
    PubMed     Abstract available


  34. NAKADE Y, Kitano R, Sakamoto K, Kimoto S, et al
    Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    PLoS One. 2021;16:e0247303.
    PubMed     Abstract available


  35. TAKASE T, Toyoda T, Kobayashi N, Inoue T, et al
    Dietary iso-alpha-acids prevent acetaldehyde-induced liver injury through Nrf2-mediated gene expression.
    PLoS One. 2021;16:e0246327.
    PubMed     Abstract available


  36. HODEIFY R, Chakkour M, Rida R, Kreydiyyeh S, et al
    PGE2 upregulates the Na+/K+ ATPase in HepG2 cells via EP4 receptors and intracellular calcium.
    PLoS One. 2021;16:e0245400.
    PubMed     Abstract available


  37. KURODA H, Fujiwara Y, Abe T, Nagasawa T, et al
    Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis.
    PLoS One. 2021;16:e0249493.
    PubMed     Abstract available


  38. D'AMBROSIO R, Campi I, Maggioni M, Perbellini R, et al
    The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2021;16:e0249614.
    PubMed     Abstract available


  39. BUSQUETS-CORTES C, Bennasar-Veny M, Lopez-Gonzalez AA, Fresneda S, et al
    Utility of Fatty Liver Index to predict reversion to normoglycemia in people with prediabetes.
    PLoS One. 2021;16:e0249221.
    PubMed     Abstract available


  40. BEYER C, Hutton C, Andersson A, Imajo K, et al
    Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort.
    PLoS One. 2021;16:e0249491.
    PubMed     Abstract available


  41. KAPS L, Ahlbrand CJ, Gadban R, Nagel M, et al
    Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care.
    PLoS One. 2021;16:e0249342.
    PubMed     Abstract available


  42. ARIYA M, Koohpayeh F, Ghaemi A, Osati S, et al
    Assessment of the association between body composition and risk of non-alcoholic fatty liver.
    PLoS One. 2021;16:e0249223.
    PubMed     Abstract available


  43. CHEN Y, Xu Z, Zeng Y, Liu J, et al
    Altered metabolism by autophagy defection affect liver regeneration.
    PLoS One. 2021;16:e0250578.
    PubMed     Abstract available


  44. TAHA MM, Aneis YM, Mohamady HM, S A A, et al
    Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    PLoS One. 2021;16:e0250337.
    PubMed     Abstract available


  45. KOUTOUKIDIS DA, Morris E, Henry JA, Shammoon Y, et al
    What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0250385.
    PubMed     Abstract available


  46. NAYAN SI, Chowdhury FI, Akter N, Rahman MM, et al
    Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats.
    PLoS One. 2021;16:e0250261.
    PubMed     Abstract available


  47. WANG R, Hu X, Liu X, Bai L, et al
    Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
    PLoS One. 2021;16:e0249881.
    PubMed     Abstract available


  48. PARK JW, Jeong JM, Cho KS, Cho SY, et al
    MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases.
    PLoS One. 2021;16:e0250083.
    PubMed     Abstract available


  49. HOSHI H, Chu PS, Yoshida A, Taniki N, et al
    Vulnerability to recurrent episodes of acute decompensation/acute-on-chronic liver failure characterizes those triggered by indeterminate precipitants in patients with liver cirrhosis.
    PLoS One. 2021;16:e0250062.
    PubMed     Abstract available


  50. KIM JY, Park YM, Lee GN, Song HC, et al
    Association between toothbrushing and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0243686.
    PubMed     Abstract available


  51. MAHRINGER-KUNZ A, Steinle V, Kloeckner R, Schotten S, et al
    The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study.
    PLoS One. 2021;16:e0249426.
    PubMed     Abstract available


  52. NG YZ, Lai LL, Wong SW, Mohamad SY, et al
    Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease.
    PLoS One. 2021;16:e0250300.
    PubMed     Abstract available


  53. EDER M, Omic H, Gorges J, Badt F, et al
    Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.
    PLoS One. 2021;16:e0249785.
    PubMed     Abstract available


  54. SAEKI C, Saito M, Kanai T, Nakano M, et al
    Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.
    PLoS One. 2021;16:e0249728.
    PubMed     Abstract available


  55. SENGUPTA M, Abuirqeba S, Kameric A, Cecile-Valfort A, et al
    A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosis.
    PLoS One. 2021;16:e0249316.
    PubMed     Abstract available


  56. KEHL T, Biermann D, Briem-Richter A, Schoen G, et al
    Impact of hepatopathy in pediatric patients after surgery for complex congenital heart disease.
    PLoS One. 2021;16:e0248776.
    PubMed     Abstract available


  57. LIN SY, Chen CM, Huang BS, Lai YC, et al
    A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness.
    PLoS One. 2021;16:e0249003.
    PubMed     Abstract available


  58. MISHIMA K, Itano O, Matsuda S, Suzuki S, et al
    Development of human hepatocellular carcinoma in X-linked severe combined immunodeficient pigs: An orthotopic xenograft model.
    PLoS One. 2021;16:e0248352.
    PubMed     Abstract available


  59. HUANG CY, Chang YJ, Wei PL, Hung CS, et al
    Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells.
    PLoS One. 2021;16:e0248521.
    PubMed     Abstract available


  60. LOOSEN SH, Castoldi M, Jordens MS, Roy S, et al
    Serum levels of circulating microRNA-107 are elevated in patients with early-stage HCC.
    PLoS One. 2021;16:e0247917.
    PubMed     Abstract available


  61. DE MUNCK TJI, Boesch M, Verhaegh P, Masclee AAM, et al
    Is there a role for neuregulin 4 in human nonalcoholic fatty liver disease?
    PLoS One. 2021;16:e0251822.
    PubMed     Abstract available


  62. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.
    PLoS One. 2021;16:e0249194.
    PubMed     Abstract available


  63. LEMIEUX S, Buies A, F Turgeon A, Hallet J, et al
    Effect of Yttrium-90 transarterial radioembolization in patients with non-surgical hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0247958.
    PubMed     Abstract available


  64. MORAN MW, Ramirez EP, Zook JD, Saarinen AM, et al
    Biophysical characterization and a roadmap towards the NMR solution structure of G0S2, a key enzyme in non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0249164.
    PubMed     Abstract available


  65. JUSTINO AB, Florentino RM, Franca A, Filho ACML, et al
    Alkaloid and acetogenin-rich fraction from Annona crassiflora fruit peel inhibits proliferation and migration of human liver cancer HepG2 cells.
    PLoS One. 2021;16:e0250394.
    PubMed     Abstract available


  66. ZHANG X, Heredia NI, Balakrishnan M, Thrift AP, et al
    Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
    PLoS One. 2021;16:e0252164.
    PubMed     Abstract available


  67. BERNARDO S, Crespo R, Saraiva S, Barata R, et al
    Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality.
    PLoS One. 2021;16:e0252218.
    PubMed     Abstract available


  68. BROERING D, Shawkat M, Albenmousa A, Abaalkhail F, et al
    Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
    PLoS One. 2021;16:e0251487.
    PubMed     Abstract available


  69. PEREIRA R, Buglevski M, Perdigoto R, Marcelino P, et al
    Intra-abdominal hypertension and abdominal compartment syndrome in the critically ill liver cirrhotic patient-prevalence and clinical outcomes. A multicentric retrospective cohort study in intensive care.
    PLoS One. 2021;16:e0251498.
    PubMed     Abstract available


  70. YOUNG P, Tarce P, Adhikary S, Connolly J, et al
    Evaluation of high-resolution melt curve analysis for rapid differentiation of Campylobacter hepaticus from other species in birds.
    PLoS One. 2021;16:e0251328.
    PubMed     Abstract available


  71. HE Y, Xu R, Peng L, Hu X, et al
    Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis.
    PLoS One. 2021;16:e0254829.
    PubMed     Abstract available


  72. DAYTON KA, Bril F, Barb D, Lai J, et al
    Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes.
    PLoS One. 2021;16:e0251449.
    PubMed     Abstract available


  73. KAPS L, Hildebrand K, Nagel M, Michel M, et al
    Risk factors for poorer health literacy in patients with liver cirrhosis.
    PLoS One. 2021;16:e0255349.
    PubMed     Abstract available


  74. LEE Y, Mun E, Park S, Lee W, et al
    Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study.
    PLoS One. 2021;16:e0255118.
    PubMed     Abstract available


  75. HALFON P, Ansaldi C, Penaranda G, Chiche L, et al
    Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results.
    PLoS One. 2021;16:e0254939.
    PubMed     Abstract available


  76. KHORPRASERT C, Thonglert K, Alisanant P, Amornwichet N, et al
    Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes.
    PLoS One. 2021;16:e0257556.
    PubMed     Abstract available


  77. WEN X, Wang S, Taveira TH, Akhlaghi F, et al
    Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
    PLoS One. 2021;16:e0251665.
    PubMed     Abstract available


  78. COUBARD OA, Ober KM, Gaumet M, Urbanski M, et al
    Standardization of the psychometric hepatic encephalopathy score in a French population.
    PLoS One. 2021;16:e0257136.
    PubMed     Abstract available


  79. CHANG Y, Han JA, Kang SM, Jeong SW, et al
    Clinical impact of serum exosomal microRNA in liver fibrosis.
    PLoS One. 2021;16:e0255672.
    PubMed     Abstract available


  80. GAO L, Morine Y, Yamada S, Saito Y, et al
    Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
    PLoS One. 2021;16:e0256755.
    PubMed     Abstract available


  81. WAQAR W, Asghar S, Manzoor S
    Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    PLoS One. 2021;16:e0256739.
    PubMed     Abstract available


  82. STRUCK MF, Kliem P, Ebel S, Bauer A, et al
    Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery.
    PLoS One. 2021;16:e0254817.
    PubMed     Abstract available


  83. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    PubMed     Abstract available


  84. SHI X, Li J, Min B, Yang R, et al
    Application of ultrasound elastography for monitoring the effects of TbetaR1 shRNA therapy on hepatic fibrosis in a rat model.
    PLoS One. 2021;16:e0253150.
    PubMed     Abstract available


  85. SHIMIZU Y, Sasaki T, Takeshita JI, Watanabe M, et al
    Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
    PLoS One. 2021;16:e0253855.
    PubMed     Abstract available


  86. LEE JW, Hwang JS, Chung WJ, Lee HJ, et al
    Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.
    PLoS One. 2021;16:e0253886.
    PubMed     Abstract available


  87. REIMER RP, Hokamp NG, Niehoff J, Zopfs D, et al
    Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.
    PLoS One. 2021;16:e0252678.
    PubMed     Abstract available


  88. JO HH, Min C, Kyoung DS, Park MA, et al
    Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study.
    PLoS One. 2021;16:e0253165.
    PubMed     Abstract available


  89. TIYARATTANACHAI T, Apiparakoon T, Marukatat S, Sukcharoen S, et al
    Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images.
    PLoS One. 2021;16:e0252882.
    PubMed     Abstract available


  90. ROUNIS K, Makrakis D, Papadaki C, Monastirioti A, et al
    Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
    PLoS One. 2021;16:e0252537.
    PubMed     Abstract available


  91. ZHOU J, Zhu Y, Ma S, Li Y, et al
    Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma.
    PLoS One. 2021;16:e0258797.
    PubMed     Abstract available


  92. XIE Y, Liu C, Zhang Y, Li A, et al
    PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair.
    PLoS One. 2021;16:e0258817.
    PubMed     Abstract available


  93. HSU PK, Wu LS, Su WW, Su PY, et al
    Comparing the controlled attenuation parameter using FibroScan and attenuation imaging with ultrasound as a novel measurement for liver steatosis.
    PLoS One. 2021;16:e0254892.
    PubMed     Abstract available


  94. ISOURA Y, Yamamoto A, Cho Y, Ehara E, et al
    Platelet count and abdominal dynamic CT are useful in predicting and screening for gastroesophageal varices after Fontan surgery.
    PLoS One. 2021;16:e0257441.
    PubMed     Abstract available


  95. WANG Y, Xiao X, Wang X, Guo F, et al
    Identification of differentially expressed long noncoding RNAs and pathways in liver tissues from rats with hepatic fibrosis.
    PLoS One. 2021;16:e0258194.
    PubMed     Abstract available


  96. KHAMIS ZI, Pang X, Cui Z, Sang QA, et al
    Cytochrome P450-2D6: A novel biomarker in liver cancer health disparity.
    PLoS One. 2021;16:e0257072.
    PubMed     Abstract available


  97. CHUAYPEN N, Limothai U, Kunadirek P, Kaewsapsak P, et al
    Identification and validation of circulating miRNAs as potential new biomarkers for severe liver disease in patients with leptospirosis.
    PLoS One. 2021;16:e0257805.
    PubMed     Abstract available


  98. PARK JH, Chung YE, Seo N, Choi JY, et al
    Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations.
    PLoS One. 2021;16:e0257308.
    PubMed     Abstract available


  99. LI M, Hu M, Yue Z, Zhang Y, et al
    The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus.
    PLoS One. 2021;16:e0257391.
    PubMed     Abstract available


  100. BHATT SP, Guleria R
    Association of IRS1 (Gly972Arg) and IRS2 (Gly1057Asp) genes polymorphisms with OSA and NAFLD in Asian Indians.
    PLoS One. 2021;16:e0245408.
    PubMed     Abstract available


  101. HUNOLD P, Berg T, Seehofer D, Sucher R, et al
    Experiences from six years of quality assured Model of End Stage Liver Disease (MELD) diagnostics.
    PLoS One. 2021;16:e0254219.
    PubMed     Abstract available


  102. YANG CJ, Wang CK, Fang YD, Wang JY, et al
    Clinical application of mask region-based convolutional neural network for the automatic detection and segmentation of abnormal liver density based on hepatocellular carcinoma computed tomography datasets.
    PLoS One. 2021;16:e0255605.
    PubMed     Abstract available


  103. MINICOZZI MR, Axlid EG, von Hippel FA, Espinoza J, et al
    Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish.
    PLoS One. 2021;16:e0254500.
    PubMed     Abstract available


  104. WU PS, Hsieh YC, Lee KC, Huang YH, et al
    Mac-2 binding protein glycosylation isomer is a potential biomarker to predict portal hypertension and bacterial infection in cirrhotic patients.
    PLoS One. 2021;16:e0258589.
    PubMed     Abstract available


  105. KOO DJ, Lee MY, Jung I, Moon SJ, et al
    Baseline homeostasis model assessment of insulin resistance associated with fibrosis progression in patients with nonalcoholic fatty liver disease without diabetes: A cohort study.
    PLoS One. 2021;16:e0255535.
    PubMed     Abstract available


  106. TRAN BV, Ujita K, Taketomi-Takahashi A, Hirasawa H, et al
    Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    PLoS One. 2021;16:e0255768.
    PubMed     Abstract available


    January 2020
  107. KLEIN WM, Sonnemans LJP, Franckenberg S, Fliss B, et al
    Pseudolesion in the right parafissural liver parenchyma on CT: The base is found in embryology and collagen content.
    PLoS One. 2020;15:e0221544.
    PubMed     Abstract available


  108. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    PubMed     Abstract available


  109. JUN BG, Lee WC, Jang JY, Jeong SW, et al
    Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection.
    PLoS One. 2020;15:e0227440.
    PubMed     Abstract available


  110. LIN Y, Li H, Jin C, Wang H, et al
    The diagnostic accuracy of liver fibrosis in non-viral liver diseases using acoustic radiation force impulse elastography: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0227358.
    PubMed     Abstract available


  111. RAHMAN MM, Zhang C, Swe KT, Rahman MS, et al
    Disease-specific out-of-pocket healthcare expenditure in urban Bangladesh: A Bayesian analysis.
    PLoS One. 2020;15:e0227565.
    PubMed     Abstract available


  112. DU S, Yang JZ, Chen J, Zhou WG, et al
    Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching.
    PLoS One. 2020;15:e0227242.
    PubMed     Abstract available


  113. HAUBOLD J, Ludwig JM, Li Y, Buechter M, et al
    Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization.
    PLoS One. 2020;15:e0227972.
    PubMed     Abstract available


  114. MATSUMOTO M, Yashiro H, Ogino H, Aoyama K, et al
    Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.
    PLoS One. 2020;15:e0228212.
    PubMed     Abstract available


  115. RAIGANI S, Karimian N, Huang V, Zhang AM, et al
    Metabolic and lipidomic profiling of steatotic human livers during ex situ normothermic machine perfusion guides resuscitation strategies.
    PLoS One. 2020;15:e0228011.
    PubMed     Abstract available


  116. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    PubMed     Abstract available


  117. OKAMOTO K, Koda M, Okamoto T, Onoyama T, et al
    Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0219412.
    PubMed     Abstract available


  118. ARTHUIS C, Diguisto C, Lorphelin H, Dochez V, et al
    Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study.
    PLoS One. 2020;15:e0228213.
    PubMed     Abstract available


  119. YANG B, Liang J, Qu Z, Yang F, et al
    Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review.
    PLoS One. 2020;15:e0227475.
    PubMed     Abstract available


  120. LANZA E, Muglia R, Bolengo I, Poretti D, et al
    Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization.
    PLoS One. 2020;15:e0227711.
    PubMed     Abstract available


  121. SEO JY, Lee JE, Chung GE, Shin E, et al
    A genome-wide association study on liver enzymes in Korean population.
    PLoS One. 2020;15:e0229374.
    PubMed     Abstract available


  122. DIAZ-RIVERA A, Meza-Rios A, Chagoya de Sanchez V, Velasco-Loyden G, et al
    Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats.
    PLoS One. 2020;15:e0228729.
    PubMed     Abstract available


  123. VAZQUEZ C, Gonzalez ML, Ferraris A, Bandi JC, et al
    Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia.
    PLoS One. 2020;15:e0228486.
    PubMed     Abstract available


  124. DINIZ MFHS, Beleigoli AMR, Bensenor IM, Lotufo PA, et al
    Association between TSH levels within the reference range and adiposity markers at the baseline of the ELSA-Brasil study.
    PLoS One. 2020;15:e0228801.
    PubMed     Abstract available


  125. LIANG X, Shu W, Linyong Z, Jianshui L, et al
    Preoperative nutritional evaluation of patients with hepatic alveolar echinococcosis.
    PLoS One. 2020;15:e0229396.
    PubMed     Abstract available


  126. CHANG TS, Tsai YH, Lin YH, Chen CH, et al
    Limited effects of antibiotic prophylaxis in patients with Child-Pugh class A/B cirrhosis and upper gastrointestinal bleeding.
    PLoS One. 2020;15:e0229101.
    PubMed     Abstract available


  127. GIANNELLI G, Santoro A, Kelley RK, Gane E, et al
    Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-betaRI inhibitor galunisertib.
    PLoS One. 2020;15:e0222259.
    PubMed     Abstract available


  128. ZHANG J, Chen G, Zhang P, Zhang J, et al
    The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0228857.
    PubMed     Abstract available


  129. KELLER LM, Eighmy S, Li C, Winter L, et al
    Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp.
    PLoS One. 2020;15:e0228985.
    PubMed     Abstract available


  130. DING W, Tan Y, Qian Y, Xue W, et al
    First-line targ veted therapies of advanced hepatocellular carcinoma: A Bayesian network analysis of randomized controlled trials.
    PLoS One. 2020;15:e0229492.
    PubMed     Abstract available


  131. MOON AM, Jiang Y, Rogal SS, Becker J, et al
    In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge.
    PLoS One. 2020;15:e0229497.
    PubMed     Abstract available


  132. LIN N, Li J, Ke Q, Xin F, et al
    Does the intermittent Pringle maneuver affect the recurrence following surgical resection for hepatocellular carcinoma? A systematic review.
    PLoS One. 2020;15:e0229870.
    PubMed     Abstract available


  133. CHOI J, Lee D, Shim JH, Kim KM, et al
    Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229696.
    PubMed     Abstract available


  134. WARD MD, King MA, Gabrial C, Kenefick RW, et al
    Biochemical recovery from exertional heat stroke follows a 16-day time course.
    PLoS One. 2020;15:e0229616.
    PubMed     Abstract available


  135. MITCHELL RA, Rathi S, Dahiya M, Zhu J, et al
    Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey.
    PLoS One. 2020;15:e0229070.
    PubMed     Abstract available


  136. YANG G, Zhang M, Zhao Y, Pan Y, et al
    HNF-4alpha inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway.
    PLoS One. 2020;15:e0230450.
    PubMed     Abstract available


  137. DIEDRICH T, Kummer S, Galante A, Drolz A, et al
    Characterization of the immune cell landscape of patients with NAFLD.
    PLoS One. 2020;15:e0230307.
    PubMed     Abstract available


  138. YEN YH, Cheng YF, Wang JH, Lin CC, et al
    Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West.
    PLoS One. 2020;15:e0230005.
    PubMed     Abstract available


  139. HEINTZ MM, McRee R, Kumar R, Baldwin WS, et al
    Gender differences in diet-induced steatotic disease in Cyp2b-null mice.
    PLoS One. 2020;15:e0229896.
    PubMed     Abstract available


  140. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    PubMed     Abstract available


  141. OKUBO H, Ando H, Ishizuka K, Kitagawa R, et al
    Carnitine insufficiency is associated with fatigue during lenvatinib treatment in patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0229772.
    PubMed     Abstract available


  142. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed     Abstract available


  143. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed     Abstract available


  144. LIU YW, Lin CC, Yong CC, Wang CC, et al
    Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center.
    PLoS One. 2020;15:e0230897.
    PubMed     Abstract available


  145. LI S, Feng X, Cao G, Wang Q, et al
    Prognostic significance of inflammatory indices in hepatocellular carcinoma treated with transarterial chemoembolization: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0230879.
    PubMed     Abstract available


  146. ZHANG F, Zhu Y, Wu S, Hou G, et al
    MLK3 is a newly identified microRNA-520b target that regulates liver cancer cell migration.
    PLoS One. 2020;15:e0230716.
    PubMed     Abstract available


  147. MIKHAIL AS, Mauda-Havakuk M, Partanen A, Karanian JW, et al
    Liver-specific 3D sectioning molds for correlating in vivo CT and MRI with tumor histopathology in woodchucks (Marmota monax).
    PLoS One. 2020;15:e0230794.
    PubMed     Abstract available


  148. ABID A, Subhani F, Kayani F, Awan S, et al
    Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan.
    PLoS One. 2020;15:e0231398.
    PubMed     Abstract available


  149. FUCHIGAMI A, Imai Y, Uchida Y, Uchiya H, et al
    Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome.
    PLoS One. 2020;15:e0231427.
    PubMed     Abstract available


  150. PIEL S, Chamkha I, Dehlin AK, Ehinger JK, et al
    Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdose.
    PLoS One. 2020;15:e0231173.
    PubMed     Abstract available


  151. YU S, Wang Y, Hou J, Li W, et al
    Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.
    PLoS One. 2020;15:e0231003.
    PubMed     Abstract available


  152. HAUKELAND JW, Smastuen MC, Palsdatter PP, Ismail M, et al
    Effect of gender on mortality and causes of death in cirrhotic patients with gastroesophageal varices. A retrospective study in Norway.
    PLoS One. 2020;15:e0230263.
    PubMed     Abstract available


  153. ZHANG M, Haughey M, Wang NY, Blease K, et al
    Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs.
    PLoS One. 2020;15:e0229445.
    PubMed     Abstract available


  154. KIRINO S, Tsuchiya K, Kurosaki M, Kaneko S, et al
    Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0231828.
    PubMed     Abstract available


  155. LIU Y, Gao H, He YD
    A compound attributes-based predictive model for drug induced liver injury in humans.
    PLoS One. 2020;15:e0231252.
    PubMed     Abstract available


  156. WU YH, Wu CY, Cheng CY, Tsai SF, et al
    Severe hyperbilirubinemia is associated with higher risk of contrast-related acute kidney injury following contrast-enhanced computed tomography.
    PLoS One. 2020;15:e0231264.
    PubMed     Abstract available


  157. SCHOMAKER S, Potter D, Warner R, Larkindale J, et al
    Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments.
    PLoS One. 2020;15:e0229753.
    PubMed     Abstract available


  158. NAKANO D, Kawaguchi T, Iwamoto H, Hayakawa M, et al
    Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT).
    PLoS One. 2020;15:e0232283.
    PubMed     Abstract available


  159. SAITO K, Fukasawa M, Shirasago Y, Suzuki R, et al
    Comparative characterization of flavivirus production in two cell lines: Human hepatoma-derived Huh7.5.1-8 and African green monkey kidney-derived Vero.
    PLoS One. 2020;15:e0232274.
    PubMed     Abstract available


  160. DAVIDSON CQ, Tharmalingam S, Niccoli S, Nemec-Bakk A, et al
    Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue.
    PLoS One. 2020;15:e0231650.
    PubMed     Abstract available


  161. BENZ F, Bogen A, Praktiknjo M, Jansen C, et al
    Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis.
    PLoS One. 2020;15:e0231701.
    PubMed     Abstract available


  162. SATAPATHY SK, Gonzalez HC, Vanatta J, Dyer A, et al
    A pilot study of ex-vivo MRI-PDFF of donor livers for assessment of steatosis and predicting early graft dysfunction.
    PLoS One. 2020;15:e0232006.
    PubMed     Abstract available


  163. RAIGANI S, Carroll C, Griffith S, Pendexter C, et al
    Improvement of steatotic rat liver function with a defatting cocktail during ex situ normothermic machine perfusion is not directly related to liver fat content.
    PLoS One. 2020;15:e0232886.
    PubMed     Abstract available


  164. CAPUTO F, Dadduzio V, Tovoli F, Bertolini G, et al
    The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
    PLoS One. 2020;15:e0232449.
    PubMed     Abstract available


  165. WELBERRY C, Macdonald I, McElveen J, Parsy-Kowalska C, et al
    Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0232247.
    PubMed     Abstract available


  166. YU Y, Bai M, Ma F, Zhang W, et al
    Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    PLoS One. 2020;15:e0232516.
    PubMed     Abstract available


  167. PETZOLD G, Lasser J, Ruhl J, Bremer SCB, et al
    Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease.
    PLoS One. 2020;15:e0231044.
    PubMed     Abstract available


  168. GRIMALDI M, Palisi A, Marino C, Montoro P, et al
    NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?
    PLoS One. 2020;15:e0231506.
    PubMed     Abstract available


  169. SI H, Genna B, Zhuang X, Wang J, et al
    DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells.
    PLoS One. 2020;15:e0231466.
    PubMed     Abstract available


  170. KANG JK, Heo S, Kim HP, Song SH, et al
    Liquid biopsy-based tumor profiling for metastatic colorectal cancer patients with ultra-deep targeted sequencing.
    PLoS One. 2020;15:e0232754.
    PubMed     Abstract available


  171. WANG Y, Zhou X, Zhao D, Wang X, et al
    Berberine inhibits free fatty acid and LPS-induced inflammation via modulating ER stress response in macrophages and hepatocytes.
    PLoS One. 2020;15:e0232630.
    PubMed     Abstract available


  172. LANZA E, Masetti C, Messana G, Muglia R, et al
    Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    PLoS One. 2020;15:e0232371.
    PubMed     Abstract available


  173. MASUYA T, Suzuki M, Tsujimura J, Kanamori S, et al
    Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice.
    PLoS One. 2020;15:e0233087.
    PubMed     Abstract available


  174. CHEN L, Zhang L, Wang W, Qiu W, et al
    Polysaccharides isolated from Cordyceps Sinensis contribute to the progression of NASH by modifying the gut microbiota in mice fed a high-fat diet.
    PLoS One. 2020;15:e0232972.
    PubMed     Abstract available


  175. BELAUNZARAN-ZAMUDIO PF, Caro-Vega Y, Giganti MJ, Castilho JL, et al
    Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America.
    PLoS One. 2020;15:e0233965.
    PubMed     Abstract available


  176. NGUYEN TN, Nguyen HQ, Le DH
    Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.
    PLoS One. 2020;15:e0229276.
    PubMed     Abstract available


  177. NAGATA S, Ozawa F, Nie M, Takeuchi S, et al
    3D culture of functional human iPSC-derived hepatocytes using a core-shell microfiber.
    PLoS One. 2020;15:e0234441.
    PubMed     Abstract available


  178. CHU YW, Chien CH, Sung MI, Chen CW, et al
    dBMHCC: A comprehensive hepatocellular carcinoma (HCC) biomarker database provides a reliable prediction system for novel HCC phosphorylated biomarkers.
    PLoS One. 2020;15:e0234084.
    PubMed     Abstract available


  179. LI C, Ge S, Zhou J, Peng J, et al
    Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma.
    PLoS One. 2020;15:e0234062.
    PubMed     Abstract available


  180. BAEZA-RAJA B, Goodyear A, Liu X, Lam K, et al
    Pharmacological inhibition of P2RX7 ameliorates liver injury by reducing inflammation and fibrosis.
    PLoS One. 2020;15:e0234038.
    PubMed     Abstract available


  181. ALBAKHEET SS, Yoon H, Shin HJ, Koh H, et al
    Bone marrow fat change in pediatric patients with non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0234096.
    PubMed     Abstract available


  182. MULEY M, Vespasiani-Gentilucci U, De Vincentis A, Santonico M, et al
    Voltammetric analysis for distinguishing portal hypertension-related from malignancy-related ascites: A proof of concept study.
    PLoS One. 2020;15:e0233350.
    PubMed     Abstract available


  183. STOCKHOFF L, Schultalbers M, Tergast TL, Hinrichs JB, et al
    Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
    PLoS One. 2020;15:e0235199.
    PubMed     Abstract available


  184. HAYASHI H, Yamashita YI, Okabe H, Imai K, et al
    Varied application of intercostal trans-diaphragmatic ports for laparoscopic hepatectomy.
    PLoS One. 2020;15:e0234919.
    PubMed     Abstract available


  185. CHANDRASHEKAR DS, Golonka RM, Yeoh BS, Gonzalez DJ, et al
    Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    PLoS One. 2020;15:e0234726.
    PubMed     Abstract available


  186. QIAO C, Qian H, Wang J, Zhao T, et al
    PD173074 blocks G1/S transition via CUL3-mediated ubiquitin protease in HepG2 and Hep3B cells.
    PLoS One. 2020;15:e0234708.
    PubMed     Abstract available


  187. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    PubMed     Abstract available


  188. KOCH C, Bette T, Waidmann O, Filmann N, et al
    AFP ratio predicts HCC recurrence after liver transplantation.
    PLoS One. 2020;15:e0235576.
    PubMed     Abstract available


  189. COHEN AM, Chamberlin S, Deloughery T, Nguyen M, et al
    Detecting rare diseases in electronic health records using machine learning and knowledge engineering: Case study of acute hepatic porphyria.
    PLoS One. 2020;15:e0235574.
    PubMed     Abstract available


  190. NICHOLS PH, Pan Y, May B, Pavlicova M, et al
    Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis.
    PLoS One. 2020;15:e0234985.
    PubMed     Abstract available


  191. SZUCS A, Paku S, Sebestyen E, Nagy P, et al
    Postnatal, ontogenic liver growth accomplished by biliary/oval cell proliferation and differentiation.
    PLoS One. 2020;15:e0233736.
    PubMed     Abstract available


  192. FORTEA JI, Puerto M, Fernandez-Mena C, Asensio I, et al
    Sevoflurane versus ketamine+diazepam anesthesia for assessing systemic and hepatic hemodynamics in rats with non-cirrhotic portal hypertension.
    PLoS One. 2020;15:e0233778.
    PubMed     Abstract available


  193. NUDISCHER R, Renggli K, Hierlemann A, Roth AB, et al
    Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity.
    PLoS One. 2020;15:e0235745.
    PubMed     Abstract available


  194. WANG J, Shen P, Liao S, Duan L, et al
    Selenoprotein P inhibits cell proliferation and ROX production in HCC cells.
    PLoS One. 2020;15:e0236491.
    PubMed     Abstract available


  195. KRISS M, Golden-Mason L, Kaplan J, Mirshahi F, et al
    Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development.
    PLoS One. 2020;15:e0236353.
    PubMed     Abstract available


  196. GOURRONC FA, Markan KR, Kulhankova K, Zhu Z, et al
    Pdgfralpha-Cre mediated knockout of the aryl hydrocarbon receptor protects mice from high-fat diet induced obesity and hepatic steatosis.
    PLoS One. 2020;15:e0236741.
    PubMed     Abstract available


  197. DIESINGER T, Buko V, Lautwein A, Dvorsky R, et al
    Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
    PLoS One. 2020;15:e0235990.
    PubMed     Abstract available


  198. OKUSHIN K, Tsutsumi T, Ikeuchi K, Kado A, et al
    Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    PLoS One. 2020;15:e0234750.
    PubMed     Abstract available


  199. PELTONEN R, Gramkow MH, Dehlendorff C, Osterlund PJ, et al
    Elevated serum YKL-40, IL-6, CRP, CEA, and CA19-9 combined as a prognostic biomarker panel after resection of colorectal liver metastases.
    PLoS One. 2020;15:e0236569.
    PubMed     Abstract available


  200. YASUI D, Yamane A, Itoh H, Kobayashi M, et al
    In vivo evaluation of a monodisperse solid-in-oil-in-water miriplatin/ lipiodol emulsion in transcatheter arterial chemoembolization using a rabbit VX2 tumor model.
    PLoS One. 2020;15:e0222553.
    PubMed     Abstract available


  201. STEMMER A, Shadmi R, Bregman-Amitai O, Chettrit D, et al
    Using machine learning algorithms to review computed tomography scans and assess risk for cardiovascular disease: Retrospective analysis from the National Lung Screening Trial (NLST).
    PLoS One. 2020;15:e0236021.
    PubMed     Abstract available


  202. SHEN Q, Hu G, Wu J, Lv L, et al
    A new clinical prognostic nomogram for liver cancer based on immune score.
    PLoS One. 2020;15:e0236622.
    PubMed     Abstract available


  203. YOO JJ, Lim YS, Kim MS, Lee B, et al
    Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer.
    PLoS One. 2020;15:e0236506.
    PubMed     Abstract available


  204. RASHIDI-ALAVIJEH J, Ceylan AS, Wedemeyer H, Kleefisch M, et al
    Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis.
    PLoS One. 2020;15:e0236528.
    PubMed     Abstract available


  205. SERPER M, Vujkovic M, Kaplan DE, Carr RM, et al
    Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program.
    PLoS One. 2020;15:e0237430.
    PubMed     Abstract available


  206. FUKUDA H, Sato D, Moriwaki K, Ishida H, et al
    Differences in healthcare expenditure estimates according to statistical approach: A nationwide claims database study on patients with hepatocellular carcinoma.
    PLoS One. 2020;15:e0237316.
    PubMed     Abstract available


  207. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    PubMed     Abstract available


  208. CHEN K, Sng WK, Quah JH, Liu J, et al
    Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus.
    PLoS One. 2020;15:e0236977.
    PubMed     Abstract available


  209. FORLANO R, Mullish BH, Mukherjee SK, Nathwani R, et al
    In-hospital mortality is associated with inflammatory response in NAFLD patients admitted for COVID-19.
    PLoS One. 2020;15:e0240400.
    PubMed     Abstract available


  210. SOGABE M, Okahisa T, Kurihara T, Takehara M, et al
    Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome.
    PLoS One. 2020;15:e0238388.
    PubMed     Abstract available


  211. TAMAI Y, Iwasa M, Eguchi A, Shigefuku R, et al
    Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma.
    PLoS One. 2020;15:e0237370.
    PubMed     Abstract available


  212. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    PubMed     Abstract available


  213. LIRA MMP, de Medeiros Filho JEM, Baccin Martins VJ, da Silva G, et al
    Association of worsening of nonalcoholic fatty liver disease with cardiometabolic function and intestinal bacterial overgrowth: A cross-sectional study.
    PLoS One. 2020;15:e0237360.
    PubMed     Abstract available


  214. RONDA OAHO, van de Heijning BJM, de Bruin A, Thomas RE, et al
    Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet.
    PLoS One. 2020;15:e0232069.
    PubMed     Abstract available


  215. LEE J, Vali Y, Boursier J, Duffin K, et al
    Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238717.
    PubMed     Abstract available


  216. ROGAL SS, Yakovchenko V, Gonzalez R, Park A, et al
    Characterizing patient-reported outcomes in veterans with cirrhosis.
    PLoS One. 2020;15:e0238712.
    PubMed     Abstract available


  217. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    PubMed     Abstract available


  218. RAJCIC D, Brandt A, Jin CJ, Sanchez V, et al
    Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance.
    PLoS One. 2020;15:e0237946.
    PubMed     Abstract available


  219. STRADOMSKA TJ, Syczewska M, Jamroz E, Pleskaczynska A, et al
    Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.
    PLoS One. 2020;15:e0238796.
    PubMed     Abstract available


  220. CORREA F, Hidalgo C, Stoore C, Jimenez M, et al
    Cattle co-infection of Echinococcus granulosus and Fasciola hepatica results in a different systemic cytokine profile than single parasite infection.
    PLoS One. 2020;15:e0238909.
    PubMed     Abstract available


  221. MAUNG K, Ramalingam S, Chaudhry M, Ren Y, et al
    Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality.
    PLoS One. 2020;15:e0238824.
    PubMed     Abstract available


  222. GRIFFETT K, Bedia-Diaz G, Elgendy B, Burris TP, et al
    REV-ERB agonism improves liver pathology in a mouse model of NASH.
    PLoS One. 2020;15:e0236000.
    PubMed     Abstract available


  223. SANTOIEMMA PP, Dakwar O, Angarone MP
    A retrospective analysis of cases of Spontaneous Bacterial Peritonitis in cirrhosis patients.
    PLoS One. 2020;15:e0239470.
    PubMed     Abstract available


  224. LOOSEN SH, Wirtz TH, Roy S, Vucur M, et al
    Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma.
    PLoS One. 2020;15:e0239386.
    PubMed     Abstract available


  225. WANG S, Toy M, Hang Pham TT, So S, et al
    Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
    PLoS One. 2020;15:e0239393.
    PubMed     Abstract available


  226. KANEKO S, Kurosaki M, Nagata K, Taki R, et al
    Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity.
    PLoS One. 2020;15:e0241663.
    PubMed     Abstract available


  227. PENG J, Zhou M, Chen C, Xie X, et al
    Identification of exacerbation risk in patients with liver dysfunction using machine learning algorithms.
    PLoS One. 2020;15:e0239266.
    PubMed     Abstract available


  228. CHOI JW, Lee JM, Lee DH, Yoon JH, et al
    Radiofrequency ablation using internally cooled wet electrodes in bipolar mode for the treatment of recurrent hepatocellular carcinoma after locoregional treatment: A randomized prospective comparative study.
    PLoS One. 2020;15:e0239733.
    PubMed     Abstract available


  229. REY R M, Delgado AF, De Zubiria A, Pinto R, et al
    Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia.
    PLoS One. 2020;15:e0239834.
    PubMed     Abstract available


  230. RIEXINGER A, Laun FB, Bickelhaupt S, Seuss H, et al
    On the dependence of the cardiac motion artifact on the breathing cycle in liver diffusion-weighted imaging.
    PLoS One. 2020;15:e0239743.
    PubMed     Abstract available


  231. MANN JP, Carter P, Armstrong MJ, Abdelaziz HK, et al
    Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    PLoS One. 2020;15:e0241357.
    PubMed     Abstract available


  232. GOODSON ML, Knotts TA, Campbell EL, Snyder CA, et al
    Specific ablation of the NCoR corepressor delta splice variant reveals alternative RNA splicing as a key regulator of hepatic metabolism.
    PLoS One. 2020;15:e0241238.
    PubMed     Abstract available


  233. KIM MC, Lee JI, Kim JH, Kim HJ, et al
    Serum zinc level and hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0240195.
    PubMed     Abstract available


  234. SORINO P, Caruso MG, Misciagna G, Bonfiglio C, et al
    Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study.
    PLoS One. 2020;15:e0240867.
    PubMed     Abstract available


  235. HASSAN S, Peluso J, Chalhoub S, Idoux Gillet Y, et al
    Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1alpha and MDR1.
    PLoS One. 2020;15:e0240676.
    PubMed     Abstract available


  236. LIN YJ, Lin CN, Sedghi T, Hsu SH, et al
    Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan.
    PLoS One. 2020;15:e0240542.
    PubMed     Abstract available


  237. ZHANG L, Yuan Q, Xu Y, Wang W, et al
    Comparative clinical outcomes of robot-assisted liver resection versus laparoscopic liver resection: A meta-analysis.
    PLoS One. 2020;15:e0240593.
    PubMed     Abstract available


  238. CHURCH RJ, Schomaker SJ, Eaddy JS, Boucher GG, et al
    Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse.
    PLoS One. 2020;15:e0240562.
    PubMed     Abstract available


  239. YAN B, Luo J, Kaltenmeier C, Du Q, et al
    Interferon Regulatory Factor-1 (IRF1) activates autophagy to promote liver ischemia/reperfusion injury by inhibiting beta-catenin in mice.
    PLoS One. 2020;15:e0239119.
    PubMed     Abstract available


  240. GRANATA V, Fusco R, Avallone A, Cassata A, et al
    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.
    PLoS One. 2020;15:e0241431.
    PubMed     Abstract available


  241. BAUMLER W, Schicho A, Schaible J, Verloh N, et al
    Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors.
    PLoS One. 2020;15:e0242093.
    PubMed     Abstract available


  242. ZHAO Y, Zhu C, Chang Q, Peng P, et al
    MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7.
    PLoS One. 2020;15:e0242179.
    PubMed     Abstract available


  243. GUO B, Tan X, Cen H
    EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma.
    PLoS One. 2020;15:e0242191.
    PubMed     Abstract available


  244. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    PubMed     Abstract available


  245. CHEN HY, Lu SN, Hung CH, Wang JH, et al
    Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation.
    PLoS One. 2020;15:e0242113.
    PubMed     Abstract available


  246. GALIERO R, Pafundi PC, Simeon V, Rinaldi L, et al
    Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study.
    PLoS One. 2020;15:e0243700.
    PubMed     Abstract available


  247. VISARIA A, Pai S, Fayngersh A, Kothari N, et al
    Association between alanine aminotransferase within the normal range and all-cause and cause-specific mortality: A nationwide cohort study.
    PLoS One. 2020;15:e0242431.
    PubMed     Abstract available


  248. SAKAMAKI A, Yokoyama K, Koyama K, Morita S, et al
    Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis.
    PLoS One. 2020;15:e0242582.
    PubMed     Abstract available


  249. PARK JH, Chung YE, Seo N, Choi JY, et al
    Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria.
    PLoS One. 2020;15:e0242344.
    PubMed     Abstract available


  250. CHOI J, Kim SH, Han S, Lee D, et al
    A simple and clinically applicable model to predict liver-related morbidity after hepatic resection for hepatocellular carcinoma.
    PLoS One. 2020;15:e0241808.
    PubMed     Abstract available


  251. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    PubMed     Abstract available


  252. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    PubMed     Abstract available


  253. LEUNG CCT, Wong CKC
    Effects of stanniocalcin-1 overexpressing hepatocellular carcinoma cells on macrophage migration.
    PLoS One. 2020;15:e0241932.
    PubMed     Abstract available


  254. PALLADINI G, Ferrigno A, Di Pasqua LG, Berardo C, et al
    Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease.
    PLoS One. 2020;15:e0243179.
    PubMed     Abstract available


  255. LUONG XG, Stevens SK, Jekle A, Lin TI, et al
    Regulation of gene transcription by thyroid hormone receptor beta agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH).
    PLoS One. 2020;15:e0240338.
    PubMed     Abstract available


  256. HIROSE S, Matsumoto K, Tatemichi M, Tsuruya K, et al
    Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients.
    PLoS One. 2020;15:e0241770.
    PubMed     Abstract available


  257. XIAO C, Fu X, Wang Y, Liu H, et al
    Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation.
    PLoS One. 2020;15:e0243812.
    PubMed     Abstract available


  258. ADHYAPOK P, Fu X, Sluka JP, Clendenon SG, et al
    A computational model of liver tissue damage and repair.
    PLoS One. 2020;15:e0243451.
    PubMed     Abstract available


  259. BRAUNWARTH E, Rumpf B, Primavesi F, Pereyra D, et al
    Sex differences in disease presentation, surgical and oncological outcome of liver resection for primary and metastatic liver tumors-A retrospective multicenter study.
    PLoS One. 2020;15:e0243539.
    PubMed     Abstract available


  260. LEE S, Kim JH, Moon H, Lee HJ, et al
    Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
    PLoS One. 2020;15:e0243815.
    PubMed     Abstract available


  261. BAYOUMI A, Jalil I, Metwally M, Adams LA, et al
    Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease.
    PLoS One. 2020;15:e0243590.
    PubMed     Abstract available


  262. BAE CR, Zhang H, Kwon YG
    The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
    PLoS One. 2020;15:e0243497.
    PubMed     Abstract available


  263. SOHN W, Ham CB, Kim NH, Kim HJ, et al
    Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    PLoS One. 2020;15:e0243780.
    PubMed     Abstract available


  264. YEN FS, Lai JN, Wei JC, Chiu LT, et al
    Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis.
    PLoS One. 2020;15:e0243783.
    PubMed     Abstract available


  265. YUAN Y, Naito H, Kitamori K, Hashimoto S, et al
    The antihypertensive agent hydralazine reduced extracellular matrix synthesis and liver fibrosis in nonalcoholic steatohepatitis exacerbated by hypertension.
    PLoS One. 2020;15:e0243846.
    PubMed     Abstract available


  266. WANG G, Wang Q, Bai J, Li G, et al
    RYGB increases postprandial gastric nesfatin-1 and rapid relieves NAFLD via gastric nerve detachment.
    PLoS One. 2020;15:e0243640.
    PubMed     Abstract available


  267. LIU L, Liu C, Zhao M, Zhang Q, et al
    The pharmacodynamic and differential gene expression analysis of PPAR alpha/delta agonist GFT505 in CDAHFD-induced NASH model.
    PLoS One. 2020;15:e0243911.
    PubMed     Abstract available


  268. MANJARIN R, Maj MA, La Frano MR, Glanz H, et al
    %polynova_2way: A SAS macro for implementation of mixed models for metabolomics data.
    PLoS One. 2020;15:e0244013.
    PubMed     Abstract available


  269. HSIEH MH, Kao TY, Hsieh TH, Kao CC, et al
    Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib.
    PLoS One. 2020;15:e0244293.
    PubMed     Abstract available


  270. WEISSINGER M, Vogel J, Kupferschlager J, Dittmann H, et al
    Correlation of C-arm CT acquired parenchymal blood volume (PBV) with 99mTc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up.
    PLoS One. 2020;15:e0244235.
    PubMed     Abstract available


  271. RYU H, Kim JH, Lee S, Han JK, et al
    Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility.
    PLoS One. 2020;15:e0244304.
    PubMed     Abstract available


  272. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    PubMed     Abstract available


  273. BORTOLAMI M, Comparato A, Benna C, Errico A, et al
    Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues.
    PLoS One. 2020;15:e0244356.
    PubMed     Abstract available


  274. HAYASHI T, Shibata M, Oe S, Miyagawa K, et al
    C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib.
    PLoS One. 2020;15:e0244370.
    PubMed     Abstract available


  275. THULUVATH PJ, Amjad W, Zhang T
    Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics.
    PLoS One. 2020;15:e0244744.
    PubMed     Abstract available


  276. PILLING D, Karhadkar TR, Gomer RH
    A CD209 ligand and a sialidase inhibitor differentially modulate adipose tissue and liver macrophage populations and steatosis in mice on the Methionine and Choline-Deficient (MCD) diet.
    PLoS One. 2020;15:e0244762.
    PubMed     Abstract available


    January 2019
  277. HOWELL AK, McCann CM, Wickstead F, Williams DJL, et al
    Co-infection of cattle with Fasciola hepatica or F. gigantica and Mycobacterium bovis: A systematic review.
    PLoS One. 2019;14:e0226300.
    PubMed     Abstract available


  278. SUDJARITRUK T, Bunupuradah T, Aurpibul L, Kosalaraksa P, et al
    Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
    PLoS One. 2019;14:e0226375.
    PubMed     Abstract available


  279. ERKAN B, Meier J, Clark TJ, Kaplan J, et al
    Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
    PLoS One. 2019;14:e0226291.
    PubMed     Abstract available


  280. ABBASS MA, Ahmad SA, Mahalingam N, Krothapalli KS, et al
    In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor.
    PLoS One. 2019;14:e0226001.
    PubMed     Abstract available


  281. SU RC, Lad A, Breidenbach JD, Blomquist TM, et al
    Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).
    PLoS One. 2019;14:e0225604.
    PubMed     Abstract available


  282. ZHONG GC, Liu S, Wu YL, Xia M, et al
    ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population.
    PLoS One. 2019;14:e0225792.
    PubMed     Abstract available


  283. SCOTT C, Stokes R, Cha KM, Clouston A, et al
    Myeloid cell deletion of Aryl hydrocarbon Receptor Nuclear Translocator (ARNT) induces non-alcoholic steatohepatitis.
    PLoS One. 2019;14:e0225332.
    PubMed     Abstract available


  284. WELDEAREGAY KT, Gebrekidan MG, Gezahegne AA
    Health impact of hepatic-venous-occlusive disease in a small town in Ethiopia-Case study from Tahtay koraro district in Tigray region, 2017.
    PLoS One. 2019;14:e0224659.
    PubMed     Abstract available


  285. SENDRA L, Herrero MJ, Montalva EM, Noguera I, et al
    Efficacy of interleukin 10 gene hydrofection in pig liver vascular isolated 'in vivo' by surgical procedure with interest in liver transplantation.
    PLoS One. 2019;14:e0224568.
    PubMed     Abstract available


  286. YANG S, Kwak S, Lee JH, Kang S, et al
    Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.
    PLoS One. 2019;14:e0224626.
    PubMed     Abstract available


  287. BUCHER JN, Koenig M, Schoenberg MB, Crispin A, et al
    Liver transplantation in patients with a history of migration-A German single center comparative analysis.
    PLoS One. 2019;14:e0224116.
    PubMed     Abstract available


  288. BAJAJ JS, Fan S, Thacker LR, Fagan A, et al
    Serum and urinary metabolomics and outcomes in cirrhosis.
    PLoS One. 2019;14:e0223061.
    PubMed     Abstract available


  289. ISHIKAWA T, Sasaki R, Nishimura T, Aibe Y, et al
    A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.
    PLoS One. 2019;14:e0223153.
    PubMed     Abstract available


  290. LIU Y, Liu X, Wang Y, Yi C, et al
    Protective effect of lactobacillus plantarum on alcoholic liver injury and regulating of keap-Nrf2-ARE signaling pathway in zebrafish larvae.
    PLoS One. 2019;14:e0222339.
    PubMed     Abstract available


  291. LEVICK C, Phillips-Hughes J, Collier J, Banerjee R, et al
    Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study.
    PLoS One. 2019;14:e0221066.
    PubMed     Abstract available


  292. MIN-DEBARTOLO J, Schlerman F, Akare S, Wang J, et al
    Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    PLoS One. 2019;14:e0226854.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: